Advances in the Synthesis of Heteroaromatic Hybrid Chalcones.
chalcone
heteroaromatic
hybrid chalcone
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
04 Apr 2023
04 Apr 2023
Historique:
received:
12
02
2023
revised:
18
03
2023
accepted:
21
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Chalcones continue to occupy a venerated status as scaffolds for the construction of a variety of heterocyclic molecules with medicinal and industrial properties. Syntheses of hybrid chalcones featuring heteroaromatic components, especially those methods utilizing green chemistry principles, are important additions to the preparative methodologies for this valuable class of molecules. This review outlines the advances made in the last few decades toward the incorporation of heteroaromatic components in the construction of hybrid chalcones and highlights examples of environmentally responsible processes employed in their preparation.
Identifiants
pubmed: 37049964
pii: molecules28073201
doi: 10.3390/molecules28073201
pmc: PMC10096121
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Front Chem. 2021 Nov 19;9:766201
pubmed: 34900935
Bioorg Med Chem. 2005 Jun 2;13(12):4007-13
pubmed: 15911313
Org Biomol Chem. 2021 May 12;19(18):4132-4136
pubmed: 33870359
Bioorg Med Chem Lett. 2017 May 15;27(10):2174-2180
pubmed: 28372908
IUCrdata. 2020 Jun 12;5(Pt 6):x200759
pubmed: 36340617
Bioorg Med Chem. 2006 Dec 1;14(23):7706-15
pubmed: 16945542
Molecules. 2012 Apr 30;17(5):4962-71
pubmed: 22547318
ACS Omega. 2018 Apr 30;3(4):4486-4493
pubmed: 30221226
Eur J Med Chem. 2018 Feb 10;145:498-510
pubmed: 29335211
RSC Adv. 2022 Apr 1;12(17):10307-10320
pubmed: 35424971
Nat Prod Res. 2014;28(7):483-7
pubmed: 24571646
Molecules. 2022 Jun 05;27(11):
pubmed: 35684559
Eur J Med Chem. 2017 Sep 8;137:126-138
pubmed: 28582669
Org Lett. 2019 Aug 2;21(15):6029-6033
pubmed: 31335151
ACS Med Chem Lett. 2019 Sep 09;10(10):1415-1422
pubmed: 31620227
Molecules. 2020 Feb 26;25(5):
pubmed: 32110945
Sci Rep. 2017 Jun 20;7(1):3919
pubmed: 28634389
Molecules. 2022 Jun 10;27(12):
pubmed: 35744875
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4985-9
pubmed: 23860591
Molecules. 2019 Sep 06;24(18):
pubmed: 31500191
Anticancer Res. 2015 Feb;35(2):811-7
pubmed: 25667461
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5270-6
pubmed: 26432037
Bioorg Med Chem Lett. 2014 Nov 15;24(22):5170-4
pubmed: 25442306
Bioorg Med Chem Lett. 2017 Jul 15;27(14):3048-3054
pubmed: 28554871
Chem Biodivers. 2021 Jul;18(7):e2100226
pubmed: 33998137
Eur J Med Chem. 2015 Jan 7;89:304-9
pubmed: 25462246
Eur J Med Chem. 2017 Mar 31;129:12-26
pubmed: 28219046
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2020 Feb 1;76(Pt 1):13-17
pubmed: 32831235
Chem Biol Drug Des. 2009 Jun;73(6):661-7
pubmed: 19635058
J Enzyme Inhib Med Chem. 2013 Jun;28(3):593-600
pubmed: 22380776
Chem Rev. 2017 Jun 28;117(12):7762-7810
pubmed: 28488435